Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1627755 | 0.85 | MAOA (0.44) | MAOAATM | |
| SCHEMBL9934275 | 0.79 | APOBEC3G (0.33) | MAOAL3MBTL1 | |
| SCHEMBL9934272 | 0.79 | MAOA (0.34) | MAOAL3MBTL1ATM | |
| SCHEMBL10513618 | 0.75 | GABRA1 (0.38) | L3MBTL1ATM | |
| SCHEMBL10422639 | 0.74 | AKR1B1 (0.43) | — | |
| SCHEMBL9934474 | 0.73 | MEN1 (0.41) | L3MBTL1ATM | |
| SCHEMBL31748025 | 0.72 | ALOX5 (0.40) | MAOAATM | |
| SCHEMBL25883001 | 0.72 | ESR1 (0.34) | L3MBTL1ATM | |
| SCHEMBL24422036 | 0.72 | ESR1 (0.34) | L3MBTL1ATM | |
| SCHEMBL1309739 | 0.69 | ALOX5 (0.38) | MAOAL3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542258-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542258-B2 | Heterocyclic compound and organic light emitting device comprising the same | CYP1A1, CRY1, CYP1B1 | RIPK1 2743/4885MAOA 176/4885L3MBTL1 1780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.